Global Ocular Pain Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ocular Pain Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Antibacterial Medications
1.2.3 Antiviral Medications
1.2.4 Steroids
1.3 Market by Application
1.3.1 Global Ocular Pain Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ocular Pain Market Perspective (2017-2028)
2.2 Ocular Pain Growth Trends by Region
2.2.1 Ocular Pain Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Ocular Pain Historic Market Size by Region (2017-2022)
2.2.3 Ocular Pain Forecasted Market Size by Region (2023-2028)
2.3 Ocular Pain Market Dynamics
2.3.1 Ocular Pain Industry Trends
2.3.2 Ocular Pain Market Drivers
2.3.3 Ocular Pain Market Challenges
2.3.4 Ocular Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ocular Pain Players by Revenue
3.1.1 Global Top Ocular Pain Players by Revenue (2017-2022)
3.1.2 Global Ocular Pain Revenue Market Share by Players (2017-2022)
3.2 Global Ocular Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ocular Pain Revenue
3.4 Global Ocular Pain Market Concentration Ratio
3.4.1 Global Ocular Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ocular Pain Revenue in 2021
3.5 Ocular Pain Key Players Head office and Area Served
3.6 Key Players Ocular Pain Product Solution and Service
3.7 Date of Enter into Ocular Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ocular Pain Breakdown Data by Type
4.1 Global Ocular Pain Historic Market Size by Type (2017-2022)
4.2 Global Ocular Pain Forecasted Market Size by Type (2023-2028)
5 Ocular Pain Breakdown Data by Application
5.1 Global Ocular Pain Historic Market Size by Application (2017-2022)
5.2 Global Ocular Pain Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Ocular Pain Market Size (2017-2028)
6.2 North America Ocular Pain Market Size by Country (2017-2022)
6.3 North America Ocular Pain Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Ocular Pain Market Size (2017-2028)
7.2 Europe Ocular Pain Market Size by Country (2017-2022)
7.3 Europe Ocular Pain Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ocular Pain Market Size (2017-2028)
8.2 Asia-Pacific Ocular Pain Market Size by Country (2017-2022)
8.3 Asia-Pacific Ocular Pain Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Ocular Pain Market Size (2017-2028)
9.2 Latin America Ocular Pain Market Size by Country (2017-2022)
9.3 Latin America Ocular Pain Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ocular Pain Market Size (2017-2028)
10.2 Middle East & Africa Ocular Pain Market Size by Country (2017-2022)
10.3 Middle East & Africa Ocular Pain Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sylentis
11.1.1 Sylentis Company Detail
11.1.2 Sylentis Business Overview
11.1.3 Sylentis Ocular Pain Introduction
11.1.4 Sylentis Revenue in Ocular Pain Business (2017-2022)
11.1.5 Sylentis Recent Development
11.2 Ocular Therapeutix
11.2.1 Ocular Therapeutix Company Detail
11.2.2 Ocular Therapeutix Business Overview
11.2.3 Ocular Therapeutix Ocular Pain Introduction
11.2.4 Ocular Therapeutix Revenue in Ocular Pain Business (2017-2022)
11.2.5 Ocular Therapeutix Recent Development
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Detail
11.3.2 Sun Pharmaceutical Business Overview
11.3.3 Sun Pharmaceutical Ocular Pain Introduction
11.3.4 Sun Pharmaceutical Revenue in Ocular Pain Business (2017-2022)
11.3.5 Sun Pharmaceutical Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Ocular Pain Introduction
11.4.4 Bayer Revenue in Ocular Pain Business (2017-2022)
11.4.5 Bayer Recent Development
11.5 InSite Vision
11.5.1 InSite Vision Company Detail
11.5.2 InSite Vision Business Overview
11.5.3 InSite Vision Ocular Pain Introduction
11.5.4 InSite Vision Revenue in Ocular Pain Business (2017-2022)
11.5.5 InSite Vision Recent Development
11.6 Reata Pharmaceuticals
11.6.1 Reata Pharmaceuticals Company Detail
11.6.2 Reata Pharmaceuticals Business Overview
11.6.3 Reata Pharmaceuticals Ocular Pain Introduction
11.6.4 Reata Pharmaceuticals Revenue in Ocular Pain Business (2017-2022)
11.6.5 Reata Pharmaceuticals Recent Development
11.7 Kala Pharmaceuticals
11.7.1 Kala Pharmaceuticals Company Detail
11.7.2 Kala Pharmaceuticals Business Overview
11.7.3 Kala Pharmaceuticals Ocular Pain Introduction
11.7.4 Kala Pharmaceuticals Revenue in Ocular Pain Business (2017-2022)
11.7.5 Kala Pharmaceuticals Recent Development
11.8 Bristol Meyer Squibb
11.8.1 Bristol Meyer Squibb Company Detail
11.8.2 Bristol Meyer Squibb Business Overview
11.8.3 Bristol Meyer Squibb Ocular Pain Introduction
11.8.4 Bristol Meyer Squibb Revenue in Ocular Pain Business (2017-2022)
11.8.5 Bristol Meyer Squibb Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Ocular Pain Introduction
11.9.4 Merck Revenue in Ocular Pain Business (2017-2022)
11.9.5 Merck Recent Development
11.10 Becton Dickinson
11.10.1 Becton Dickinson Company Detail
11.10.2 Becton Dickinson Business Overview
11.10.3 Becton Dickinson Ocular Pain Introduction
11.10.4 Becton Dickinson Revenue in Ocular Pain Business (2017-2022)
11.10.5 Becton Dickinson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Ocular Pain Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Antibacterial Medications
Table 3. Key Players of Antiviral Medications
Table 4. Key Players of Steroids
Table 5. Global Ocular Pain Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Ocular Pain Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Ocular Pain Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Ocular Pain Market Share by Region (2017-2022)
Table 9. Global Ocular Pain Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Ocular Pain Market Share by Region (2023-2028)
Table 11. Ocular Pain Market Trends
Table 12. Ocular Pain Market Drivers
Table 13. Ocular Pain Market Challenges
Table 14. Ocular Pain Market Restraints
Table 15. Global Ocular Pain Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Ocular Pain Market Share by Players (2017-2022)
Table 17. Global Top Ocular Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Pain as of 2021)
Table 18. Ranking of Global Top Ocular Pain Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Ocular Pain Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ocular Pain Product Solution and Service
Table 22. Date of Enter into Ocular Pain Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ocular Pain Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Ocular Pain Revenue Market Share by Type (2017-2022)
Table 26. Global Ocular Pain Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Ocular Pain Revenue Market Share by Type (2023-2028)
Table 28. Global Ocular Pain Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Ocular Pain Revenue Market Share by Application (2017-2022)
Table 30. Global Ocular Pain Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Ocular Pain Revenue Market Share by Application (2023-2028)
Table 32. North America Ocular Pain Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Ocular Pain Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Ocular Pain Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Ocular Pain Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Ocular Pain Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Ocular Pain Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Ocular Pain Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Ocular Pain Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Ocular Pain Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Ocular Pain Market Size by Country (2023-2028) & (US$ Million)
Table 42. Sylentis Company Detail
Table 43. Sylentis Business Overview
Table 44. Sylentis Ocular Pain Product
Table 45. Sylentis Revenue in Ocular Pain Business (2017-2022) & (US$ Million)
Table 46. Sylentis Recent Development
Table 47. Ocular Therapeutix Company Detail
Table 48. Ocular Therapeutix Business Overview
Table 49. Ocular Therapeutix Ocular Pain Product
Table 50. Ocular Therapeutix Revenue in Ocular Pain Business (2017-2022) & (US$ Million)
Table 51. Ocular Therapeutix Recent Development
Table 52. Sun Pharmaceutical Company Detail
Table 53. Sun Pharmaceutical Business Overview
Table 54. Sun Pharmaceutical Ocular Pain Product
Table 55. Sun Pharmaceutical Revenue in Ocular Pain Business (2017-2022) & (US$ Million)
Table 56. Sun Pharmaceutical Recent Development
Table 57. Bayer Company Detail
Table 58. Bayer Business Overview
Table 59. Bayer Ocular Pain Product
Table 60. Bayer Revenue in Ocular Pain Business (2017-2022) & (US$ Million)
Table 61. Bayer Recent Development
Table 62. InSite Vision Company Detail
Table 63. InSite Vision Business Overview
Table 64. InSite Vision Ocular Pain Product
Table 65. InSite Vision Revenue in Ocular Pain Business (2017-2022) & (US$ Million)
Table 66. InSite Vision Recent Development
Table 67. Reata Pharmaceuticals Company Detail
Table 68. Reata Pharmaceuticals Business Overview
Table 69. Reata Pharmaceuticals Ocular Pain Product
Table 70. Reata Pharmaceuticals Revenue in Ocular Pain Business (2017-2022) & (US$ Million)
Table 71. Reata Pharmaceuticals Recent Development
Table 72. Kala Pharmaceuticals Company Detail
Table 73. Kala Pharmaceuticals Business Overview
Table 74. Kala Pharmaceuticals Ocular Pain Product
Table 75. Kala Pharmaceuticals Revenue in Ocular Pain Business (2017-2022) & (US$ Million)
Table 76. Kala Pharmaceuticals Recent Development
Table 77. Bristol Meyer Squibb Company Detail
Table 78. Bristol Meyer Squibb Business Overview
Table 79. Bristol Meyer Squibb Ocular Pain Product
Table 80. Bristol Meyer Squibb Revenue in Ocular Pain Business (2017-2022) & (US$ Million)
Table 81. Bristol Meyer Squibb Recent Development
Table 82. Merck Company Detail
Table 83. Merck Business Overview
Table 84. Merck Ocular Pain Product
Table 85. Merck Revenue in Ocular Pain Business (2017-2022) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Becton Dickinson Company Detail
Table 88. Becton Dickinson Business Overview
Table 89. Becton Dickinson Ocular Pain Product
Table 90. Becton Dickinson Revenue in Ocular Pain Business (2017-2022) & (US$ Million)
Table 91. Becton Dickinson Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Ocular Pain Market Share by Type: 2021 VS 2028
Figure 2. Antibacterial Medications Features
Figure 3. Antiviral Medications Features
Figure 4. Steroids Features
Figure 5. Global Ocular Pain Market Share by Application in 2021 & 2028
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Others Case Studies
Figure 9. Ocular Pain Report Years Considered
Figure 10. Global Ocular Pain Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Ocular Pain Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Ocular Pain Market Share by Region: 2021 VS 2028
Figure 13. Global Ocular Pain Market Share by Players in 2021
Figure 14. Global Top Ocular Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Pain as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Ocular Pain Revenue in 2021
Figure 16. North America Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Ocular Pain Market Share by Country (2017-2028)
Figure 18. United States Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Ocular Pain Market Share by Country (2017-2028)
Figure 22. Germany Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Ocular Pain Market Share by Region (2017-2028)
Figure 30. China Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Ocular Pain Market Share by Country (2017-2028)
Figure 38. Mexico Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Ocular Pain Market Share by Country (2017-2028)
Figure 42. Turkey Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Ocular Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Sylentis Revenue Growth Rate in Ocular Pain Business (2017-2022)
Figure 45. Ocular Therapeutix Revenue Growth Rate in Ocular Pain Business (2017-2022)
Figure 46. Sun Pharmaceutical Revenue Growth Rate in Ocular Pain Business (2017-2022)
Figure 47. Bayer Revenue Growth Rate in Ocular Pain Business (2017-2022)
Figure 48. InSite Vision Revenue Growth Rate in Ocular Pain Business (2017-2022)
Figure 49. Reata Pharmaceuticals Revenue Growth Rate in Ocular Pain Business (2017-2022)
Figure 50. Kala Pharmaceuticals Revenue Growth Rate in Ocular Pain Business (2017-2022)
Figure 51. Bristol Meyer Squibb Revenue Growth Rate in Ocular Pain Business (2017-2022)
Figure 52. Merck Revenue Growth Rate in Ocular Pain Business (2017-2022)
Figure 53. Becton Dickinson Revenue Growth Rate in Ocular Pain Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed